Post-stroke depression: Diagnosis and therapy;Diagnostik und therapie der depression nach schlaclanfall

Fortschritte der Neurologie Psychiatrie

Volumn 69, Issue 12, 2001, Pages 581-591

  Huff, W ^a   Ruhrmann, S ^a   Sitzer, M ^b  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; BUSPIRONE; CITALOPRAM; DESIPRAMINE; DOXEPIN; FLUOXETINE; IMIPRAMINE; METHYLPHENIDATE; MIANSERIN; MIRTAZAPINE; NORTRIPTYLINE; PAROXETINE; PLACEBO; PSYCHOSTIMULANT AGENT; SEROTONIN AGONIST; SEROTONIN UPTAKE INHIBITOR; TETRACYCLIC ANTIDEPRESSANT AGENT; TRANQUILIZER; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE CLASSIFICATION; ELECTROSTIMULATION THERAPY; HUMAN; META ANALYSIS; PREVALENCE; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; STROKE; TREATMENT OUTCOME;

EID: 0035677174     PISSN: 07204299     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-19183     Document Type: Article

References (93)

1. Depression, introversion and mortality following stroke
2. Poststroke depression: Prevalence, course and associated factors
3. Poststroke depression: An examination of the literature
4. Affective disorders and cerebral vascular disease
5. Reduction of CSF monoamine metabolites in poststroke depression: A preliminary report
6. Depressive changes in stroke patients
7. The post-stroke depression rating scale: A test specifically devised to investigate affective orders of stroke patients
8. Depressive verstimmung im akutstadium nach erstmaligem ischämischen hirninfarkt
9. Relationship between depression and cerebrovascular disease: Conceptual issues
10. Antidepressants drug treatment for post-stroke depression: Retrospective study
11. The impact of poststroke depression on recovery in activities of daily living over a 2-year follow-up
12. Affective disorders after stroke
13. Major depression in stroke patients: A 3-year longitudinal study
14. Depressive disorders in long-term survivors of stroke: Associations with demographic and social factors, functional status, and brain lesion volume
15. Assessment and psychologic factors in stroke rehabilitation
16. Rehabilitation nach schlaganfall - Kognitive defizite, depressivität und lebenszufriedenheit nach schlaganfall
17. The relationship between social impairment and recovery from stroke
18. Improved recovery in activities of daily living associated with remission of poststroke depression
19. Mood disorder following CVA
20. Increase of medical hospital length of stay by depression in stroke and amputation patients: A pilot study
21. Quality of life after a first ischemic stroke. Long term developments and correlations with changes in neurological deficit, mood and cognitive impairment
22. Depression and other determinants of values placed on current health state by stroke patients
23. Association of depression with 10-year post-stroke-mortality
24. Prevalence of depression after stroke: The Perth Community Stroke study
25. The unmet needs of stroke survivors
26. Psychosozial disability in physically restored long-term stroke survivors
27. Post-stroke depression and pathological crying: Clinical aspects and new pharmacological approaches
28. Functional impairment associated with acute poststroke depression: The stroke data bank study
29. Diagnostic criteria for use in psychiatric research
30. The validity of observed depression as a criteria for mood disorders in patients with acute stroke
31. The diagnosis and treatment of post-stroke depression
32. The CES-D Scale: A self report depression scale for research in the general population
33. A self-rating depression scale
34. Screening tests for geriatric depression
35. A rating scale for depression
36. Use of the Cornell scale in nondemented patients
37. A comprehensive psychopathological rating scale
38. A new depression scale designed to be sensitive to change
39. Mood change following left hemispheric brain injury
40. Screening for depression in stroke patients: The reliability and validity of the Center for Epidemiologic Studies Depression Scale
41. The sensitivity and specifity of the Center for Epidemiologic Studies in Depression Scale for post-stroke depression
42. Comparison of six depression rating scales in geriatric stroke patients
43. Depression in aphasic Patients: Frequency, severity and clinical-pathological correlations
44. The relationship of depression to symtomatology and lesion site in aphasic patients
45. Depression in acute and chronic aphasia: Symptoms, pathoanatomical-clinical correlations and functional implications
46. The assessment of depression in aphasic stroke patients: The development of the Stroke Aphasic Depression Questionnaire
47. Antidepressant drug treatment for poststroke depression: Retrospective study
48. Nortriptyline treatment of poststroke depression: A double-blind treatment trial
49. Treatment of cognitive impairment after poststroke depression
50. Poststroke depression: Combined treatment with imipramine or desipramine and mianserin: A controlled study
51. Effective treament of poststroke depression with the selective serotonin reuptake inhibitor citalopram
52. Use of sertraline (an SSR1) in Chinese elderly stroke patients with depression
53. Behandlung der frühen post-stroke-depression mit venlafaxin: Sicherheit, verträglichkeit und wirksamkeit in einer offenen klinischen studie
54. Poststroke depression and fluoxetine
55. Anger attacks in poststroke depression: Response to fluoxetine
56. Fluoxetine in early poststroke depression
57. Depressive störungen in der neurologischen rehabilitation: Therapie mit paroxetin
58. Mirtazepine-induced mania in a case of poststroke depression
59. Psychostimulants in post-stroke depression
60. Methylphenidate in stroke patients with depression
61. Methylphenidate in treating poststroke depression
62. Efficacy and side effects of methylphenidate for post-stroke depression
63. Methylphenidate in early poststroke recovery: A double-blind, placebo-controlled study
64. Methylphenidate treatment of poststroke depression in a patient with global aphasia
65. Alternative treatment for poststroke depression
66. Effects of early treatment of post-stroke depression on neuropsychological rehabilitation
67. Methylphenidate and nortriptyline in the treatment of poststroke depression: A retrospective comparison
68. Therapy of depression in poststroke patients
69. Effects of antidepressants on functional recovery following stroke: A double-blind study
70. The psychotherapeutic treatment of post-stroke depression with cognitive behavioral therapy
71. Psychological management of post-stroke depression
72. Evaluation of cognitive behavioural treatment for depression after stroke: A pilot study
73. Modification of cognitive psychotherapy for the treatment of post-stroke depression
74. Cognitive therapy and the treatment of poststroke depression
75. Depression following stroke: Brief, problem-focused family treatment
76. Stages in coping after stroke
77. Electroconvulsive therapy for poststroke depression
78. ECT-Induced interictal delirium in patients with a history of a CVA
79. Prevention of poststroke depression: 1 Year randomised placebo controlled double blind trial of mianserin with 6 month follow up after therapy
80. Does Sertraline induced platelet dysfunction protect stroke patients against cardiovaskular comorbidity
81. Antidepressant therapy after stroke: A double-blind trial
82. Effects of fluoxetin and maprotilin on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy
83. Nortriptyline versus Fluoxetine in the treatment of depression and in short-term recovery after stroke: A placebo-controlled, double blind study